Trending Stock News

As Crown Holdings (CCK) Market Value Rose, Shareholder Janney Montgomery Scott Has Cut Holding; Merck & Company (MRK) Shareholder Stonebridge Capital Management Has Upped Stake by $1.11 Million as Stock Value Declined

Stonebridge Capital Management Inc increased its stake in Merck & Company (MRK) by 57.69% based on its latest 2017Q3 regulatory filing with the SEC. Stonebridge Capital Management Inc bought 17,288 shares as the company’s stock declined 2.46% while stock markets rallied. The institutional investor held 47,254 shares of the health care company at the end of 2017Q3, valued at $3.03M, up from 29,966 at the end of the previous reported quarter. Stonebridge Capital Management Inc who had been investing in Merck & Company for a number of months, seems to be bullish on the $149.57B market cap company. It closed at $54.9 lastly. It is down 16.86% since February 15, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Janney Montgomery Scott Llc decreased its stake in Crown Holdings Inc (CCK) by 66.12% based on its latest 2017Q3 regulatory filing with the SEC. Janney Montgomery Scott Llc sold 9,343 shares as the company’s stock rose 6.12% with the market. The institutional investor held 4,788 shares of the consumer durables company at the end of 2017Q3, valued at $286,000, down from 14,131 at the end of the previous reported quarter. Janney Montgomery Scott Llc who had been investing in Crown Holdings Inc for a number of months, seems to be less bullish one the $6.80 billion market cap company. The stock increased 0.06% or $0.03 during the last trading session, reaching $50.65. About 1.93M shares traded or 24.18% up from the average. Crown Holdings, Inc. (NYSE:CCK) has risen 7.50% since February 15, 2017 and is uptrending. It has underperformed by 9.20% the S&P500.

Investors sentiment decreased to 1.06 in Q3 2017. Its down 0.01, from 1.07 in 2017Q2. It dropped, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Thompson Inv holds 0.25% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 20,969 shares. Fairfield Bush And invested 0.26% in Merck & Co., Inc. (NYSE:MRK). Retail Bank Of America De reported 0.43% in Merck & Co., Inc. (NYSE:MRK). Sigma Planning has 0.26% invested in Merck & Co., Inc. (NYSE:MRK). Northstar Grp Inc reported 13,106 shares or 0.48% of all its holdings. Stanley reported 8,827 shares or 0.15% of all its holdings. Oarsman Capital accumulated 3,412 shares. Portland Glob Advisors Limited Liability Corp has 0.58% invested in Merck & Co., Inc. (NYSE:MRK) for 23,743 shares. Moreover, Eos Limited Partnership has 0.14% invested in Merck & Co., Inc. (NYSE:MRK) for 6,979 shares. Thrivent For Lutherans reported 0.56% in Merck & Co., Inc. (NYSE:MRK). Levin Strategies Limited Partnership invested in 0.73% or 670,541 shares. Cardinal Capital reported 1.32% in Merck & Co., Inc. (NYSE:MRK). Iberiabank Corp holds 1% or 94,200 shares in its portfolio. Tealwood Asset Management Inc reported 86,342 shares stake. Brown Brothers Harriman reported 0.07% of its portfolio in Merck & Co., Inc. (NYSE:MRK).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 17 have Buy rating, 0 Sell and 7 Hold. Therefore 71% are positive. Merck & Co. Inc. had 79 analyst reports since August 13, 2015 according to SRatingsIntel. The company was maintained on Friday, September 8 by Credit Suisse. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Outperform” rating by Credit Suisse on Wednesday, August 30. The rating was maintained by UBS on Monday, October 30 with “Buy”. BMO Capital Markets maintained it with “Buy” rating and $7200 target in Friday, August 4 report. The stock of Merck & Co., Inc. (NYSE:MRK) has “Market Perform” rating given on Monday, October 30 by Leerink Swann. The firm has “Hold” rating by Jefferies given on Thursday, July 14. The firm has “Buy” rating by Piper Jaffray given on Friday, July 28. The stock has “Sell” rating by BMO Capital Markets on Tuesday, July 4. The stock has “Buy” rating by UBS on Monday, July 31. Cowen & Co maintained the stock with “Market Perform” rating in Wednesday, April 12 report.

Stonebridge Capital Management Inc, which manages about $462.82 million and $265.71M US Long portfolio, decreased its stake in Gilead Sciences Inc C (NASDAQ:GILD) by 11,315 shares to 41,795 shares, valued at $3.39 million in 2017Q3, according to the filing.

Janney Montgomery Scott Llc, which manages about $15.70B and $8.78 billion US Long portfolio, upped its stake in Hlthcr Sel Sect Spdr Etf (XLV) by 208,955 shares to 1.68 million shares, valued at $137.30 million in 2017Q3, according to the filing. It also increased its holding in Vngrd Shrt Trm Corp Etf (VCSH) by 51,402 shares in the quarter, for a total of 531,985 shares, and has risen its stake in Aflac Inc (NYSE:AFL).

Among 15 analysts covering Crown Holdings (NYSE:CCK), 9 have Buy rating, 0 Sell and 6 Hold. Therefore 60% are positive. Crown Holdings had 43 analyst reports since July 22, 2015 according to SRatingsIntel. Bank of America upgraded Crown Holdings, Inc. (NYSE:CCK) on Friday, February 19 to “Buy” rating. BMO Capital Markets maintained the stock with “Buy” rating in Friday, June 23 report. The firm has “Neutral” rating given on Tuesday, September 15 by Bank of America. Jefferies maintained the shares of CCK in report on Thursday, July 14 with “Buy” rating. As per Tuesday, July 18, the company rating was maintained by Deutsche Bank. On Wednesday, July 22 the stock rating was upgraded by TheStreet to “Buy”. The firm has “Buy” rating given on Monday, August 28 by Jefferies. Vertical Research downgraded the shares of CCK in report on Monday, April 25 to “Hold” rating. Jefferies maintained it with “Buy” rating and $7000 target in Thursday, July 13 report. The rating was downgraded by Vertical Research on Friday, July 21 to “Hold”.

Investors sentiment increased to 1.16 in 2017 Q3. Its up 0.31, from 0.85 in 2017Q2. It improved, as 23 investors sold CCK shares while 96 reduced holdings. 43 funds opened positions while 95 raised stakes. 119.77 million shares or 0.32% less from 120.15 million shares in 2017Q2 were reported. Hl Fin Ser Llc invested in 0.01% or 6,066 shares. New York-based Gabelli Funds Llc has invested 0.09% in Crown Holdings, Inc. (NYSE:CCK). Qs Investors Llc holds 67,088 shares. Korea Investment Corp has invested 0.01% in Crown Holdings, Inc. (NYSE:CCK). Emerald Advisers Incorporated Pa holds 0.08% or 34,809 shares in its portfolio. Archon Ptnrs Ltd Com reported 79,813 shares. Cwm Ltd Liability Corporation accumulated 30 shares or 0% of the stock. Lpl Financial Limited Com stated it has 11,370 shares. Raymond James And Assoc has 0.02% invested in Crown Holdings, Inc. (NYSE:CCK) for 199,949 shares. Los Angeles Cap Management Equity Rech invested in 726,995 shares or 0.25% of the stock. United Kingdom-based Gsa Capital Prns Limited Liability Partnership has invested 0.05% in Crown Holdings, Inc. (NYSE:CCK). Lsv Asset Management has invested 0.02% in Crown Holdings, Inc. (NYSE:CCK). New York-based M&T National Bank & Trust Corporation has invested 0% in Crown Holdings, Inc. (NYSE:CCK). Pitcairn invested in 8,532 shares. Cibc Ww Markets Incorporated has invested 0% of its portfolio in Crown Holdings, Inc. (NYSE:CCK).

Leave a Reply

Your email address will not be published. Required fields are marked *